KERYX BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 492515951. A total of 4 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $110,000 | -12.0% | 32,400 | -2.7% | 0.00% | 0.0% |
Q2 2018 | $125,000 | -58.6% | 33,300 | -54.9% | 0.00% | -66.7% |
Q1 2018 | $302,000 | -61.1% | 73,800 | -55.8% | 0.00% | -40.0% |
Q4 2017 | $777,000 | -48.1% | 167,000 | -20.8% | 0.01% | -64.3% |
Q3 2017 | $1,497,000 | +58.4% | 210,800 | +61.3% | 0.01% | +40.0% |
Q2 2017 | $945,000 | +23.5% | 130,700 | +5.2% | 0.01% | +11.1% |
Q1 2017 | $765,000 | -41.9% | 124,200 | -44.8% | 0.01% | -30.8% |
Q4 2016 | $1,317,000 | +101.7% | 224,800 | +82.9% | 0.01% | +85.7% |
Q3 2016 | $653,000 | +132.4% | 122,900 | +189.2% | 0.01% | +133.3% |
Q2 2016 | $281,000 | +32.5% | 42,500 | -6.4% | 0.00% | 0.0% |
Q1 2016 | $212,000 | -81.9% | 45,400 | -80.5% | 0.00% | -78.6% |
Q4 2015 | $1,174,000 | +57.6% | 232,500 | +9.8% | 0.01% | +40.0% |
Q3 2015 | $745,000 | -69.0% | 211,700 | -12.0% | 0.01% | -70.6% |
Q2 2015 | $2,401,000 | +17.9% | 240,600 | +50.5% | 0.03% | +6.2% |
Q1 2015 | $2,036,000 | -49.0% | 159,900 | -43.3% | 0.03% | -46.7% |
Q4 2014 | $3,992,000 | +15.9% | 282,100 | +12.7% | 0.06% | +13.2% |
Q3 2014 | $3,443,000 | +5.2% | 250,400 | +17.7% | 0.05% | +6.0% |
Q2 2014 | $3,273,000 | -41.3% | 212,800 | -34.9% | 0.05% | -46.8% |
Q1 2014 | $5,574,000 | -8.3% | 327,100 | -30.3% | 0.09% | +2.2% |
Q4 2013 | $6,080,000 | +79.2% | 469,500 | +39.8% | 0.09% | +41.5% |
Q3 2013 | $3,392,000 | +11.7% | 335,800 | -17.4% | 0.06% | -13.3% |
Q2 2013 | $3,037,000 | – | 406,500 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 282,100 | $3,992,000 | 0.06% |
SABBY MANAGEMENT, LLC | 128 | $181,000 | 0.01% |
Citadel Advisors | 108,400 | $1,534,000 | 0.00% |
SIMPLEX TRADING, LLC | 91 | $16,000 | 0.00% |